BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Debt Components
- 2026-06-30: Short-term DebtUSD $1.26M; Debt Instrument, Fee AmountUSD (m); Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m).
- 2026-03-31: Short-term DebtUSD $1.33M; Debt Instrument, Fee AmountUSD (m); Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m).
- 2025-12-31: Short-term DebtUSD $967.00K; Debt Instrument, Fee AmountUSD (m); Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m).
- 2025-11-10: Short-term DebtUSD (m); Debt Instrument, Fee AmountUSD $3.50M; Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m).
BRAINSTORM CELL THERAPEUTICS INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Short-term Debt USD | Debt Instrument, Fee Amount USD | Convertible Notes Payable, Current USD | Convertible Notes Payable USD | Debt Instrument, Convertible, Beneficial Conversion Feature USD |
|---|---|---|---|---|---|
| 2026-06-30 | $1.26M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $1.33M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $967.00K | (m) | (m) | (m) | (m) |
| 2025-11-10 | (m) | $3.50M | (m) | (m) | (m) |
| 2025-09-30 | $101.00K | (m) | (m) | (m) | (m) |
| 2025-06-30 | $101.00K | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.20M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $300.00K | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2011-06-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2010-12-31 | (m) | (m) | $137.00K | (m) | (m) |
| 2009-12-13 | (m) | (m) | (m) | $135.00K | (m) |
| 2007-12-31 | (m) | (m) | (m) | (m) | 12 month · $407.00K |
| 2006-12-31 | (m) | (m) | (m) | (m) | 9 month · $1.09M |
| 2006-03-31 | (m) | (m) | (m) | (m) | 12 month · $164.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |